Summary
Pfizer Inc. (PFE) filed an 8-K on July 27, 2021, to report its financial results for the second quarter of 2021, as announced in a press release dated July 28, 2021. The filing primarily serves to furnish the press release, which contains the company's operational and financial performance for the period. Investors should refer to the press release (Exhibit 99) for detailed financial figures and operational updates. The furnished information, while providing key quarterly results, is not deemed "filed" under Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities as formally filed documents. However, it remains a crucial source of information for understanding Pfizer's recent performance and outlook as communicated by the company.
Key Highlights
- 1Pfizer announced its second quarter 2021 financial results via a press release on July 28, 2021.
- 2The 8-K filing on July 27, 2021, primarily incorporates this press release as Exhibit 99.
- 3Investors can find detailed operational and financial performance for Q2 2021 within the furnished press release.
- 4The information furnished under Item 2.02 is for disclosure purposes and is not legally "filed" under Section 18 of the Exchange Act.
- 5The filing includes the standard Cover Page Interactive Data File (XBRL).